This browser doesn't support Spotify Web Player. Switch browsers or download Spotify for your desktop.

PeerVoice Heart & Lung Audio

By PeerVoice

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

  1. 1.
    Deciphering the Role of MET Alterations in Advanced NSCLC: Unmet Needs09/28/2020
    15:42
  2. 2.
    New Targets, New Hope in SMA: A 2020 Congress Coverage09/18/2020
    8:18
  3. 3.
    Extending Your Interdisciplinary Understanding of IL-6R Inhibitors in Rheumatoid Arthritis09/07/2020
    1:15:18
  4. 4.
    New Targets, New Hope in SMA: A 2020 Congress Coverage09/04/2020
    27:48
  5. 5.
    Managing Complicated Cases in Type 2 Diabetes06/08/2020
    14:24
  6. 6.
    Individualising Stroke Prevention in Older Adults With Atrial Fibrillation (How I Treat)04/15/2020
    14:27
  7. 7.
    Acute Polyneuropathy With Abdominal Pain: Could It be Acute Hepatic Porphyria?04/13/2020
    15:02
  8. 8.
    Imagining a World Without Hepatitis C Virus: A Call to Action04/02/2020
    10:03
  1. 9.
    Heart Matters in T2DM: The Experts Weigh In04/02/2020
    25:39
  2. 10.
    Individualising HIV Care to Optimise Outcomes: Clinical Points of View and Practical Considerations for Switching ART03/27/2020
    23:23
  3. 11.
    "Managing Stroke Risk Due to Atrial Fibrillation in Older Patients: Expert Perspectives"01/08/2020
    21:30
  4. 12.
    Managing Lipid-Related Cardiovascular Risk: What We Know Now01/06/2020
    19:23
  5. 13.
    Setting a Path for Success in Type 2 Diabetes: What We Know Now11/08/2019
    1:11:20
  6. 14.
    Warming Up to Novel Approaches for Primary Cold Agglutinin Disease: Strategies for Correct Diagnosis and Optimal Treatment11/04/2019
    16:08
  7. 15.
    Evaluating the Latest Data in Ulcerative Colitis11/01/2019
    17:29
  8. 16.
    PARP Inhibitors for Ovarian Cancer: Making the Right Choices at the Right Times10/30/2019
    9:52
  9. 17.
    Getting at the Heart of Comprehensive Disease Control in Type 2 Diabetes: What’s New?10/23/2019
    1:17:18
  10. 18.
    Paving the Way to Better Outcomes in EGFR-Mutant NSCLC: Time to Take a Step Further?10/16/2019
    1:07:42
  11. 19.
    Expert Advice on Uncontrolled Asthma: Should I Consider a Biologic for This Patient?10/07/2019
    25:01
  12. 20.
    Meeting the Clinical Challenge: Individualising Anticoagulation for Patients With AF and ACS06/14/2019
    23:25
  13. 21.
    A Case for Clarity: Putting the Latest Recommendations for IPF Into Context04/22/2019
    10:09
  14. 22.
    A Closer Look at Safety of Glucose-Lowering Therapy02/27/2019
    18:46
  15. 23.
    Wheeze, Asthma, and Lung Function: Latest Insights on the Long-Term Impact of Severe RSV in Infancy12/28/2018
    16:44
  16. 24.
    Current Clinical Challenges in CF Management: Review of the Evidence by the Experts12/11/2018
    25:10
  17. 25.
    Debated Issues in the Prevention of Severe RSV in Infants12/07/2018
    32:36
  18. 26.
    Biomarkers in Lung Cancer: Targeting the Right Patient With the Right Therapy11/26/2018
    1:14:45
  19. 27.
    How a New Understanding of Severe Asthma Is Changing Treatment Paradigms11/23/2018
    19:37
  20. 28.
    Double Trouble: The Impact of Viral and Bacterial Coinfection in Children With RSV-CAAP and What to Do About It11/14/2018
    16:56
  21. 29.
    Improving Outcomes in Type 2 Diabetes: Focus on Cardiovascular and Renal Safety11/06/2018
    1:13:39
  22. 30.
    Stroke Prevention in Atrial Fibrillation: Lessons from Real-World Studies10/24/2018
    21:59
  23. 31.
    Endotyping Severe Asthma: For Which Patients and Why?10/12/2018
    16:41
  24. 32.
    Learning From the Literature: New Data for Improving CF Management and Patient Outcomes09/17/2018
    20:05
  25. 33.
    Type 2 Inflammation in Severe Asthma: What Does It Mean Today?09/05/2018
    14:54
  26. 34.
    Balancing Safety With Stroke Prevention in High-Risk Patients With AF08/31/2018
    15:12
  27. 35.
    Best Practices in Managing CML08/17/2018
    17:59
  28. 36.
    Clinical Updates: New Pathways and Strategies in Small-Cell Lung Cancer07/04/2018
    19:09
  29. 37.
    Tips and Tricks in Diagnosis and Treatment of Idiopathic Pulmonary Fibrosis06/15/2018
    25:47
  30. 38.
    Improving Clinical Management of Patients with Heart Failure06/01/2018
    15:08
  31. 39.
    Emerging Biomarkers in Small-Cell Lung Cancer: A New Era04/30/2018
    16:44
  32. 40.
    Cardiovascular and Renal Safety in Type 2 Diabetes: What Clinicians Need to Know04/20/2018
    20:44
  33. 41.
    New Strategies, New Targets: The Evolving Landscape in Driver-Mutation–Positive Advanced NSCLC04/09/2018
    11:04
  34. 42.
    Defining the Optimal Respiratory Syncytial Virus Infection Management Strategy: Applying Health Economics to Improve Patient Outcomes04/02/2018
    19:07
  35. 43.
    Improving Outcomes for VTE in Cancer: The Role of Oral Anticoagulants03/19/2018
    20:08

Listen to PeerVoice Heart & Lung Audio now.

Listen to PeerVoice Heart & Lung Audio in full in the Spotify app